Nanobiotix at ASTRO 2020

ASTRO's roots date back slightly more than a half-century. In 1950, America's radiotherapists started gathering at Chicago each year to discuss their work. In 1955, some of the most important people practicing radiation therapy in the United States met every year, this formed the nucleus for what would become the largest and most influential meeting for the radiation oncology community.

Due to the actual COVID-19 crisis and for health and safety reasons, the 2020 annual meeting will be held in virtual format from October 25-28.

The theme of the 2020 ASTRO Annual Meeting is Global Oncology: Radiation Therapy In A Changing World. The scientific research presented at the annual meeting is an invaluable asset to both academic and community radiation oncology practices around the world. This year’s annual meeting will have more than 200 sessions and 2,800 abstracts through live, SimuLive and onDemand presentations including the Plenary and Clinical Trials sessions and digital posters with author narration and Q&A.

Join us at the 2020 ASTRO Annual Meeting!

Nanobiotix will be presenting new valuable data evaluating the potential of NBTXR3 to improve treatment outcomes for cancer patients. We will be sharing an update of our ongoing studies in Head & Neck, Liver and Immuno-Oncology!

This year, we are proud to have 3 abstracts approved for digital poster presentation. You can find more information about this by visiting the ASTRO website.

Register on ASTRO Annual Meeting Website